Glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null polymorphisms, smoking, and their interaction in oral cancer: A HuGE review and meta-analysis

American Journal of Epidemiology

Volumn 173, Issue 8, 2011, Pages 847-857

  Zhang, Zhi Jiang ^a   Hao, Ke ^b   Shi, Rong ^a   Zhao, Genming ^c   Jiang, Guo Xin ^d   Song, Yiqing ^e   Xu, Xiaohui ^f   Ma, Jin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Rosetta Inpharmatics   (United States)

^c FUDAN UNIVERSITY   (China)

^d KAROLINSKA INSTITUTE   (Sweden)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f UNIVERSITY OF FLORIDA   (United States)

Author keywords

case control studies; genome, human; glutathione transferase; interaction; meta analysis; mouth neoplasms; polymorphism, genetic; polymorphism, single nucleotide

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

CANCER; ENZYME ACTIVITY; GENETIC ANALYSIS; GENOTYPE; HEALTH RISK; LITERATURE REVIEW; META-ANALYSIS; ORAL HEALTH; POLYMORPHISM; SMOKING;

ARTICLE; ASIAN; CAUCASIAN; ENZYME POLYMORPHISM; GENETIC ASSOCIATION; GENOTYPE; HUMAN; META ANALYSIS (TOPIC); MOUTH CANCER; PROTEIN INTERACTION; SMOKING; SYSTEMATIC REVIEW;

ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION STUDIES; GLUTATHIONE TRANSFERASE; HUMANS; MOUTH NEOPLASMS; POLYMORPHISM, GENETIC; SMOKING;

SCOPUS;

EID: 79953897039     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwq480     Document Type: Article

References (76)

1. Petersen PE. Oral cancer prevention and control-the approach of the World Health Organization. Oral Oncol. 2009;45(4-5):454-460.
2. Gómez I, Seoane J, Varela-Centelles P, et al. Is diagnostic delay related to advanced-stage oral cancer? A meta-analysis. Eur J Oral Sci. 2009;117(5):541-546.
3. Sato M, Sato T, Izumo T, et al. Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer. Carcinogenesis. 1999;20(10):1927- 1931. (Pubitemid 29476118)
4. Hung HC, Chuang J, Chien YC, et al. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev. 1997;6(11):901-905. (Pubitemid 27481638)
5. Katoh T, Kaneko S, Kohshi K, et al. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and oral cavity cancer. Int J Cancer. 1999;83(5):606-609. (Pubitemid 29508037)
6. Xie H, Hou L, Shields PG, et al. Metabolic polymorphisms, smoking, and oral cancer in Puerto Rico. Oncol Res. 2004;14(6):315-320.
7. Sharma A, Mishra A, Das BC, et al. Genetic polymorphism at GSTM1 and GSTT1 gene loci and susceptibility to oral cancer. Neoplasma. 2006;53(4):309-315. (Pubitemid 44105936)
8. Cha IH, Park JY, Chung WY, et al. Polymorphisms of CYP1A1 and GSTM1 genes and susceptibility to oral cancer. Yonsei Med J. 2007;48(2):233-239. (Pubitemid 46711753)
9. Buch SC, Notani PN, Bhisey RA. Polymorphism at GSTM1, GSTM3 and GSTT1 gene loci and susceptibility to oral cancer in an Indian population. Carcinogenesis. 2002;23(5):803-807. (Pubitemid 34567519)
10. Sugimura T, Kumimoto H, Tohnai I, et al. Gene-environment interaction involved in oral carcinogenesis: molecular epide-miological study for metabolic and DNA repair gene polymorphisms. J Oral Pathol Med. 2006;35(1):11-18.
11. Schilter B, Turesky RJ, Juillerat M, et al. Phase I and phase II xenobiotic reactions and metabolism of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in aggregating liver cell cultures. Biochem Pharmacol. 1993; 45(5):1087-1096. (Pubitemid 23079986)
12. Seidegard J, Vorachek WR, Pero RW, et al. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA. 1988;85(19):7293-7297.
13. Gronau S, Koenig-Greger D, Jerg M, et al. GSTM1 enzyme concentration and enzyme activity in correlation to the genotype of detoxification enzymes in squamous cell carcinoma of the oral cavity. Oral Dis. 2003;9(2):62-67. (Pubitemid 36460016)
14. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoen-zymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30(6):445-600.
15. Amtha R, Ching CS, Zain R, et al. GSTM1, GSTT1 and CYP1A1 polymorphisms and risk of oral cancer: a case-control study in Jakarta, Indonesia. Asian Pac J Cancer Prev. 2009;10(1):21-26.
16. Anantharaman D, Chaubal PM, Kannan S, et al. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis. 2007;28(7):1455-1462. (Pubitemid 47241795)
17. Bathi RJ, Rao R, Mutalik S. GST null genotype and antiox-idants: risk indicators for oral pre-cancer and cancer. Indian J Dent Res. 2009;20(3):298-303.
18. Chen MK, Tsai HT, Chung TT, et al. Glutathione S-transferase P1 and alpha gene variants; role in susceptibility and tumor size development of oral cancer. Head Neck. 2010;32(8):1079-1087.
19. Deakin M, Elder J, Hendrickse C, et al. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis. 1996;17(4):881-884. (Pubitemid 26129707)
20. Drummond SN, Gomez RS, Motta Noronha JC, et al. Association between GSTT-1 gene deletion and the susceptibility to oral squamous cell carcinoma in cigarette-smoking subjects. Oral Oncol. 2005;41(5):515-519. (Pubitemid 40692853)
21. Gattás GJ, de Carvalho MB, Siraque MS, et al. Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer. Head Neck. 2006;28(9): 819-826. (Pubitemid 44320536)
22. Jourenkova-Mironova N, Voho A, Bouchardy C, et al. Glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes and the risk of smoking-related oral and pharyngeal cancers. Int J Cancer. 1999;81(1):44-48. (Pubitemid 29124195)
23. Kietthubthew S, Sriplung H, Au WW. Genetic and environmental interactions on oral cancer in Southern Thailand. Environ Mol Mutagen. 2001;37(2):111-116. (Pubitemid 32295110)
24. Liu CJ, Chang CS, Lui MT, et al. Association of GST genotypes with age of onset and lymph node metastasis in oral squamous cell carcinoma. J Oral Pathol Med. 2005;34(8): 473-477.
25. Majumder M, Sikdar N, Paul RR, et al. Increased risk of oral leukoplakia and cancer among mixed tobacco users carrying XRCC1 variant haplotypes and cancer among smokers carrying two risk genotypes: one on each of two loci, GSTM3 and XRCC1 (codon 280). Cancer Epidemiol Biomarkers Prev. 2005;14(9):2106-2112. (Pubitemid 41603253)
26. Sreelekha TT, Ramadas K, Pandey M, et al. Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol. 2001;37(7):593-598. (Pubitemid 32889622)
27. Drummond SN, De Marco L, Noronha JC, et al. GSTM1 polymorphism and oral squamous cell carcinoma. Oral Oncol. 2004;40(1):52-55. (Pubitemid 37510212)
28. Hahn M, Hagedorn G, Kuhlisch E, et al. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to oral cavity cancer. Oral Oncol. 2002;38(5):486-490. (Pubitemid 34756735)
29. Nomura T, Noma H, Shibahara T, et al. Aldehyde dehydro-genase 2 and glutathione S-transferase M 1 polymorphisms in relation to the risk for oral cancer in Japanese drinkers. Oral Oncol. 2000;36(1):42-46.
30. Park JY, Muscat JE, Ren Q, et al. CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol Bio-markers Prev. 1997;6(10):791-797. (Pubitemid 27435477)
31. Tanimoto K, Hayashi S, Yoshiga K, et al. Polymorphisms of the CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose. Oral Oncol. 1999;35(2):191-196. (Pubitemid 29113063)
32. Varela-Lema L, Ruano-Ravina A, Juiz Crespo MA, et al. CYP1A1, mEH, and GSTM1 polymorphisms and risk of oral and pharyngeal cancer: a Spanish case-control study. J Oncol. 2008;2008:741310. (doi: 10.1155/2008/741310).
33. Sharma R, Ahuja M, Panda NK, et al. Combined effect of smoking and polymorphisms in tobacco carcinogen-metabolizing enzymes CYP1A1 and GSTM1 on the head and neck cancer risk in north Indians. DNA Cell Biol. 2010;29(8): 441-448.
34. Zhuo W, Wang Y, Zhuo X, et al. CYP1A1 and GSTM1 polymorphisms and oral cancer risk: association studies via evidence-based meta-analyses. Cancer Invest. 2009;27(1): 86-95.
35. Kenborg L, Jørgensen AD, Budtz-Jørgensen E, et al. Occupational exposure to the sun and risk of skin and lip cancer among male wage earners in Denmark: a population-based case-control study. Cancer Causes Control. 2010;21(8): 1347-1355.
36. Alderson P, Green S, Higgins JPT, eds. Cochrane reviewers' handbook 4.2.2 [updated March 2004]. In: Cochrane Library, Issue 1, 2004. Chichester, United Kingdom: John Wiley & Sons Ltd, 2004:102-153.
37. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188. (Pubitemid 17189972)
38. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4): 1088-1101.
39. Piegorsch WW, Weinberg CR, Taylor JA. Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies. Stat Med. 1994;13(2):153-162. (Pubitemid 24017109)
40. Khoury MJ, Flanders WD. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am J Epidemiol. 1996;144(3):207-213. (Pubitemid 26313497)
41. Yang Q, Khoury MJ, Flanders WD. Sample size requirements in case-only designs to detect gene-environment interaction. Am J Epidemiol. 1997;146(9):713-720.
42. Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol. 2005;28(2): 123-137.
43. Moonesinghe R, Khoury MJ, Janssens AC. Most published research findings are false-but a little replication goes a long way. PLoS Med. 2007;4(2):e28. (doi: 10.1371/journal.pmed. 0040028).
44. Moonesinghe R, Khoury MJ, Liu T, et al. Required sample size and nonreplicability thresholds for heterogeneous genetic associations. Proc Natl Acad Sci USA. 2008;105(2):617-622. (Pubitemid 351171757)
45. Lin PI, Vance JM, Pericak-Vance MA, et al. No gene is an island: the flip-flop phenomenon. Am J Hum Genet. 2007;80(3):531-538.
46. Lohmueller KE, Pearce CL, Pike M, et al. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet. 2003;33(2):177-182. (Pubitemid 36177070)
47. Zeggini E, Ioannidis JP. Meta-analysis in genome-wide association studies. Pharmacogenomics. 2009;10(2):191-201.
48. Carlsten C, Sagoo GS, Frodsham AJ, et al. Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol. 2008;167(7):759-774. (Pubitemid 351451750)
49. Shi X, Zhou S, Wang Z, et al. CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis. Lung Cancer. 2008;59(2):155-163. (Pubitemid 351173406)
50. London SJ, Yuan JM, Chung FL, et al. Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet. 2000;356(9231):724-729. (Pubitemid 30663242)
51. Yu KD, Di GH, Fan L, et al. A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer. FASEB J. 2009;23(7):2274-2287.
52. Garća-Closas M, Malats N, Silverman D, et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet. 2005;366(9486):649-659. (Pubitemid 41176017)
53. Sikdar N, Paul RR, Roy B. Glutathione S-transferase M3 (A/A) genotype as a risk factor for oral cancer and leukoplakia among Indian tobacco smokers. Int J Cancer. 2004;109(1): 95-101. (Pubitemid 38160667)
54. Matthias C, Bockmühl U, Jahnke V, et al. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and gluta-thione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics. 1998;8(2):91-100. (Pubitemid 28227316)
55. Hatagima A, Costa EC, Marques CF, et al. Glutathione S-transferase polymorphisms and oral cancer: a case-control study in Rio de Janeiro, Brazil. Oral Oncol. 2008;44(2): 200-207. (Pubitemid 351193012)
56. Park LY, Muscat JE, Kaur T, et al. Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and Caucasians. Pharmacogenetics. 2000;10(2): 123-131. (Pubitemid 30193074)
57. Huang P, An Y, Wu C, et al. GSTM1 polymorphisms and oral and maxillofacial cancer. J Pract Oncol. 2006;21(1): 39-42.
58. van der Hel OL, Bueno de Mesquita HB, Roest M, et al. No modifying effect of NAT1, GSTM1, and GSTT1 on the relation between smoking and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2003;12(7):681-682. (Pubitemid 36899854)
59. Lam TK, Ruczinski I, Helzlsouer K, et al. Copy number variants of GSTM1 and GSTT1 in relation to lung cancer risk in a prospective cohort study. Ann Epidemiol. 2009;19(8): 546-552.
60. Nishino K, Sekine M, Kodama S, et al. Cigarette smoking and glutathione S-transferase M1 polymorphism associated with risk for uterine cervical cancer. J Obstet Gynaecol Res. 2008;36(4):994-1001.
61. Risch A, Ramroth H, Raedts V, et al. Laryngeal cancer risk in Caucasians is associated with alcohol and tobacco consumption but not modified by genetic polymorphisms in class I alcohol dehydrogenases ADH1B and ADH1C, and gluta-thione- S-transferases GSTM1 and GSTT1. Pharmacoge-netics. 2003;13(4):225-230. (Pubitemid 36543395)
62. Wang AH, Sun CS, Li LS, et al. Relationship of tobacco smoking, CYP1A1, GSTM1 gene polymorphism and esophageal cancer in Xi'an. World J Gastroenterol. 2002;8(1):49-53.
63. Singh M, Shah PP, Singh AP, et al. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer. Mutat Res. 2008; 638(1-2):184-194.
64. Soya SS, Vinod T, Reddy KS, et al. Genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) and upper aerodigestive tract cancer risk among smokers, tobacco chewers and alcoholics in an Indian population. Eur J Cancer. 2007;43(18):2698-2706. (Pubitemid 350151835)
65. Lee KM, Kang D, Clapper ML, et al. CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations. Cancer Epidemiol Biomarkers Prev. 2008;17(5):1120-1126.
66. Raimondi S, Paracchini V, Autrup H, et al. Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol. 2006;164(11):1027- 1042. (Pubitemid 44851738)
67. Saadat M. Genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and susceptibility to gastric cancer: a meta-analysis. Cancer Sci. 2006;97(6):505-509. (Pubitemid 43811592)
68. Ye Z, Song H. Glutathione s-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: a systematic review and meta-analysis. Eur J Cancer. 2005;41(7):980-989. (Pubitemid 40602849)
69. White DL, Li D, Nurgalieva Z, et al. Genetic variants of glu-tathione S-transferase as possible risk factors for hepatocel-lular carcinoma: a HuGE systematic review and meta-analysis. Am J Epidemiol. 2008;167(4):377-389. (Pubitemid 351264139)
70. Zhuo X, Cai L, Xiang Z, et al. GSTM1 and GSTT1 polymorphisms and nasopharyngeal cancer risk: an evidence-based meta-analysis. J Exp Clin Cancer Res. 2009;28:46. (doi: 10.1186/1756-9966-28-46).
71. Geisler SA, Olshan AF. GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: a mini-HuGE review. Am J Epidemiol. 2001;154(2):95-105. (Pubitemid 32643123)
72. Bull LM, White DL, Bray M, et al. Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis. Dis Esophagus. 2009;22(7):571-587.
73. Egan KM, Cai Q, Shu XO, et al. Genetic polymorphisms in GSTM1, GSTP1, and GSTT1 and the risk for breast cancer: results from the Shanghai Breast Cancer Study and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2004;13(2): 197-204. (Pubitemid 38222549)
74. Ntais C, Polycarpou A, Ioannidis JP. Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2005;14(1):176-181. (Pubitemid 40165300)
75. Ioannidis JP, Trikalinos TA, Khoury MJ. Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am J Epidemiol. 2006;164(7):609-614. (Pubitemid 44453487)
76. Trikalinos TA, Salanti G, Khoury MJ, et al. Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am J Epidemiol. 2006;163(4):300-309. (Pubitemid 43238423)